Bioavailability of Four Oral Prototype Extended Release Formulations With BI 11634 in Healthy Male Volunteers

NCT02214953 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

17

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: BI 11634 ER formulation A
DRUG: BI 11634 ER formulation B
DRUG: BI 11634 ER formulation M
DRUG: BI 11634 ER formulation C
DRUG: BI 11634 IR tablet

Sponsor

Boehringer Ingelheim